Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16336294rdf:typepubmed:Citationlld:pubmed
pubmed-article:16336294lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0016860lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0032821lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0683149lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0527379lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0700452lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0700492lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0264716lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:16336294lifeskim:mentionsumls-concept:C0723423lld:lifeskim
pubmed-article:16336294pubmed:issue6lld:pubmed
pubmed-article:16336294pubmed:dateCreated2005-12-12lld:pubmed
pubmed-article:16336294pubmed:abstractTextTo retrospectively investigate elevation of serum potassium when spironolactone (25 or 50 mg/day) and furosemide were administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) to patients with chronic heart failure for 12 months and occurrence of hyperkalemia and hypokalemia because of concomitant administration of spironolactone plus an ACE-I or ARB and furosemide.lld:pubmed
pubmed-article:16336294pubmed:languageenglld:pubmed
pubmed-article:16336294pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:citationSubsetIMlld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16336294pubmed:statusMEDLINElld:pubmed
pubmed-article:16336294pubmed:monthDeclld:pubmed
pubmed-article:16336294pubmed:issn0269-4727lld:pubmed
pubmed-article:16336294pubmed:authorpubmed-author:SaitoMMlld:pubmed
pubmed-article:16336294pubmed:authorpubmed-author:TakadaMMlld:pubmed
pubmed-article:16336294pubmed:authorpubmed-author:HirookaKKlld:pubmed
pubmed-article:16336294pubmed:authorpubmed-author:IsobeFFlld:pubmed
pubmed-article:16336294pubmed:authorpubmed-author:YasumuraYYlld:pubmed
pubmed-article:16336294pubmed:issnTypePrintlld:pubmed
pubmed-article:16336294pubmed:volume30lld:pubmed
pubmed-article:16336294pubmed:ownerNLMlld:pubmed
pubmed-article:16336294pubmed:authorsCompleteYlld:pubmed
pubmed-article:16336294pubmed:pagination603-10lld:pubmed
pubmed-article:16336294pubmed:dateRevised2008-5-28lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:meshHeadingpubmed-meshheading:16336294...lld:pubmed
pubmed-article:16336294pubmed:year2005lld:pubmed
pubmed-article:16336294pubmed:articleTitleSerum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.lld:pubmed
pubmed-article:16336294pubmed:affiliationDepartment of Pharmacy, National Hospital Organization Osaka Medical Center, Japan. m-saito@onh.go.jplld:pubmed
pubmed-article:16336294pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16336294pubmed:publicationTypeClinical Triallld:pubmed